These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29169088)

  • 1. Systematically investigating the impact of medication on the gut microbiome.
    Maier L; Typas A
    Curr Opin Microbiol; 2017 Oct; 39():128-135. PubMed ID: 29169088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bringing microbiome-drug interaction research into the clinic.
    Guthrie L; Kelly L
    EBioMedicine; 2019 Jun; 44():708-715. PubMed ID: 31151933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional genomic and metagenomic approaches to understanding gut microbiota-animal mutualism.
    Yoon SS; Kim EK; Lee WJ
    Curr Opin Microbiol; 2015 Apr; 24():38-46. PubMed ID: 25625313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between drugs and the gut microbiome.
    Weersma RK; Zhernakova A; Fu J
    Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-gut microbiota interactions: implications for neuropharmacology.
    Walsh J; Griffin BT; Clarke G; Hyland NP
    Br J Pharmacol; 2018 Dec; 175(24):4415-4429. PubMed ID: 29782640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
    Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
    Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Reciprocal Interactions between Polyphenols and Gut Microbiota and Effects on Bioaccessibility.
    Ozdal T; Sela DA; Xiao J; Boyacioglu D; Chen F; Capanoglu E
    Nutrients; 2016 Feb; 8(2):78. PubMed ID: 26861391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenobiotics: Interaction with the Intestinal Microflora.
    Lu K; Mahbub R; Fox JG
    ILAR J; 2015; 56(2):218-27. PubMed ID: 26323631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics.
    Wilkinson EM; Ilhan ZE; Herbst-Kralovetz MM
    Maturitas; 2018 Jun; 112():53-63. PubMed ID: 29704918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics and the developing infant gut microbiota and resistome.
    Gibson MK; Crofts TS; Dantas G
    Curr Opin Microbiol; 2015 Oct; 27():51-6. PubMed ID: 26241507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of the Human Gut Microbiome on Therapeutics.
    Vázquez-Baeza Y; Callewaert C; Debelius J; Hyde E; Marotz C; Morton JT; Swafford A; Vrbanac A; Dorrestein PC; Knight R
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():253-270. PubMed ID: 28968189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
    Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
    J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.
    Nagatomo Y; Tang WH
    J Card Fail; 2015 Dec; 21(12):973-80. PubMed ID: 26435097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To engraft or not to engraft: an ecological framework for gut microbiome modulation with live microbes.
    Walter J; Maldonado-Gómez MX; Martínez I
    Curr Opin Biotechnol; 2018 Feb; 49():129-139. PubMed ID: 28866242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribed Drugs and the Microbiome.
    Brusselaers N
    Gastroenterol Clin North Am; 2019 Sep; 48(3):331-342. PubMed ID: 31383274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
    Liu X; Cao S; Zhang X
    J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New frontiers in nanotoxicology: Gut microbiota/microbiome-mediated effects of engineered nanomaterials.
    Pietroiusti A; Magrini A; Campagnolo L
    Toxicol Appl Pharmacol; 2016 May; 299():90-5. PubMed ID: 26723910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Specific Effects of Arsenic Exposure on the Trajectory and Function of the Gut Microbiome.
    Chi L; Bian X; Gao B; Ru H; Tu P; Lu K
    Chem Res Toxicol; 2016 Jun; 29(6):949-51. PubMed ID: 27268458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.